Zonisamide
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Zonisamide is an antiseizure medication used for focal-onset seizures. It is a sulfonamide and carbonic anhydrase inhibitor, so serious rash, metabolic acidosis, kidney stones, oligohidrosis, and heat illness are key safety concerns. Folate lowering has been reported with some antiseizure therapies, and bicarbonate monitoring is clinically important because zonisamide can reduce serum bicarbonate.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Zonisamide is an antiseizure medication used for focal-onset seizures. NutriStack rates the supporting evidence as strong. Common adult dosing is Common adult initiation is 100 mg daily, titrating after 2 weeks toward 200 mg/day and then 300-400 mg/day; doses above 400 mg/day may be used selectively but adverse effects increase., though a prescriber sets the actual dose. With long-term use it can deplete bicarbonate, folate. This profile indexes 3 sources.
- Adjunctive treatment of focal-onset seizures
- Reduction in seizure frequency
- Once-daily or twice-daily dosing because of long half-life
The bottom line
Evidence rating strong. Most-documented uses: adjunctive treatment of focal-onset seizures, reduction in seizure frequency, once-daily or twice-daily dosing because of long half-life. 3 sources indexed (2002–2026), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Zonisamide appears to reduce seizure activity through voltage-gated sodium-channel blockade, T-type calcium-channel effects, and carbonic anhydrase inhibition. Carbonic anhydrase inhibition can cause renal bicarbonate loss and chronic metabolic acidosis, increasing risk of kidney stones and bone effects. Sulfonamide-related hypersensitivity can lead to severe skin, hepatic, hematologic, or multiorgan reactions.2,3
Dosing & protocol.
May be taken with or without food. Adequate hydration is important to reduce kidney stone risk.2
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Bicarbonate
SignificantCarbonic anhydrase inhibition increases renal bicarbonate loss, producing a non-anion-gap metabolic acidosis with reduced serum bicarbonate.
Folate
MildLong-term antiseizure therapy has been associated with reduced folate status in some patients; the evidence is stronger for older enzyme-inducing drugs but folate monitoring is reasonable when risk factors or deficiency signs are present.
Full safety detail.
Side effects
- Somnolence
- Dizziness
- Anorexia or weight loss
- Ataxia
- Cognitive slowing
- Metabolic acidosis with low serum bicarbonate
- Kidney stones
- Oligohidrosis and hyperthermia
- Serious sulfonamide reactions including Stevens-Johnson syndrome or toxic epidermal necrolysis
- DRESS or multiorgan hypersensitivity
- Suicidal thoughts or behavior warning for antiepileptic drugs
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Reviews & position papers
1- 1Antiepileptic drugs and folate metabolismMorrell MJ · Epilepsy and Behavior · 2002
Review discusses folate considerations in people receiving long-term antiseizure therapy.
Reference material
2- 2ZONISAMIDE capsules, US Prescribing InformationURLU.S. National Library of Medicine · DailyMed · 2026
Capsule labeling reports a plasma half-life of about 63 hours and cautions that steady state may take up to 2 weeks after dose changes.
- 3ZONISADE (zonisamide) oral suspension, US Prescribing InformationURLAzurity Pharmaceuticals Inc. · DailyMed · 2025
Labeling specifies 100 mg daily initiation, metabolic acidosis warnings, sulfonamide reactions, kidney stones, and hydration considerations.
Common questions.
Quick answers about Zonisamide, drawn from the data on this page.
What is Zonisamide?
Zonisamide is an antiseizure medication used for focal-onset seizures. It is a sulfonamide and carbonic anhydrase inhibitor, so serious rash, metabolic acidosis, kidney stones, oligohidrosis, and heat illness are key safety concerns. Folate lowering has been reported with some antiseizure therapies, and bicarbonate monitoring is clinically important because zonisamide can reduce serum bicarbonate.
What is Zonisamide used for?
Commonly cited benefits of Zonisamide include: Adjunctive treatment of focal-onset seizures; Reduction in seizure frequency; Once-daily or twice-daily dosing because of long half-life. NutriStack rates the overall evidence as strong.
What is a typical dose of Zonisamide?
A typical adult dose of Zonisamide is Common adult initiation is 100 mg daily, titrating after 2 weeks toward 200 mg/day and then 300-400 mg/day; doses above 400 mg/day may be used selectively but adverse effects increase.. The commonly recommended form is Oral capsule or oral suspension. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Zonisamide?
Reported side effects include somnolence, dizziness, anorexia or weight loss, ataxia, cognitive slowing, metabolic acidosis with low serum bicarbonate. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Zonisamide?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Zonisamide in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.